Pharmaceuticals
News on pharmaceuticals
Fine hospitals restricting bowel cancer care, charity says
Hospitals that fail to offer bowel cancer patients a full range of appropriate treatments should be fined, a charity has said.
New Medicine Service guidance released
New guidance has been published showing how the New Medicine Service and post discharge Medicines Use Reviews can be used to provide a seamless care pathway for patients who transfer from hospital to the community setting.
Royal Liverpool submits planning application for BioInnovation centre
COMMERCIAL: The trust has submitted a planning application for a 70,000 sq ft Liverpool BioInnovation Centre, to provide commercial scale laboratory space to develop new treatments and medical technologies for the market.
Lansley vows to enforce drugs access rules
Legislation meant to end the variable access to drugs in NHS hospitals will be enforced, the health secretary has told the Commons.
Clinical data regulation not robust, say experts
Leading doctors have called for an end to “incomplete data disclosure” and more robust regulation of information in clinical trials.
Patient data 'assurances' needed for private sector data sharing - Burnham
Government plans to give NHS patients’ details to private firms developing new drugs must give “assurance” that privacy safeguards will be in place.
Privacy concerns over Cameron NHS data sharing plan
The prime minister David Cameron will today signal controversial moves to boost the economy by sharing NHS data with private healthcare companies.
UHB to become 'magnet' for pharma money and clinical research after hook-up with uni
COMMERCIAL: University Hospitals Birmingham Foundation Trust and the University of Birmingham has today announced a joint working agreement to be known as Birmingham Health Partners (BHP).
Pharma suppliers put export ahead of NHS - Burns
Drugs for NHS patients are being delayed because suppliers make more money by selling medication to eurozone countries, the government has said.
Guidance 'misconstrued' as commissioners restrict drugs
Primary care trusts are “misconstruing” official drugs guidance in order to restrict access to treatments, a coalition of patient bodies has warned.
South West trusts sign pharma research deal
COMMERCIAL: Five NHS trusts have begun working with the world’s biggest biopharmaceutical company to provide patients for clinical trials.
Hospital pharmacy shop opens at East Cheshire
COMMERCIAL: An over-the-counter pharmacy shop has been opened this month at Macclesfield District General Hospital.
£625m synthetic insulin had 'no clinical benefit'
The NHS has spent hundreds of millions of pounds on synthetic insulin unnecessarily over the past decade, according to a report published today.
Co-op wins Doncaster & Bassetlaw Hospitals FT contract
COMMERCIAL: The Co-operative Pharmacy has been awarded a seven year outpatient dispensing contract with Doncaster & Bassetlaw Hospitals NHS Foundation Trust.
Pharma sector calls on trusts to share data with industry
The pharmaceutical industry is urging the NHS to be more open to research projects which could illuminate the wider societal benefits of treatment.
Kent named as a ‘Healthy Living Pharmacy’ pathfinder
STRUCTURE: Kent has been selected as one of 20 national pathfinders sites for Healthy Living Pharmacies, which integrate pharmacy services with public health.
-
Cancer drug access unequal across UK
-
Bolton GP commissioners forecast to overspend delegated budgets by £1.4m
-
£800m funding injection for medical research
-
NHS Somerset delegates medicines to GPs
-
DH report finds medicines waste 'not a systemic problem'
-
GPs could be influenced by pharma, King's Fund warns
-
Wastage efficiency drive launched by DH
-
New money-saving medicines scheme a step closer
-
Cancer tsar calls for radiotherapy investment
-
Prescription costs soar over last decade
-
Value based pricing not 'feasible' by 2014
-
Rare cancer drugs budget underspent by nearly half
-
Royal Cornwall Hospitals signs pharmacy deal with Lloyds
-
Prescriptions bill up £300m despite improved value for money
News by sector
How CCGs can make savings in their prescription budget
Providing GPs with the right support on prescribing can realistically deliver savings for CCGs in their prescription budgets that could make a significant dent in an annual NHS spend of £8bn a year, says Claire Forde.
Understanding non-compliance to improve patient behaviours
There are many myths about compliance in patient behaviour, writes Jane Shirely, so getting to the truth of the matter is important if rates of non-compliance and their costly consequences are to be reduced.
Managing medicines: avoiding ethical and legal difficulties
Substituting expensive medicines for less costly alternatives might be a measure earmarked for cutting costs, but financial and legal issues surround this approach and need careful adherence, warns Peter Feldschreiber.
Can competition transform healthcare delivery in the NHS?
With competition at the core of the government’s NHS redesign, the goal should be improved health output at lower cost. But can competition be used to improve healthcare without increasing market costs or slashing employee compensation and engagement, asks Stephen Sellery.
How NHS collaboration with the pharma industry could benefit both players
The challenge to find cost-savings while innovating services presents issues for both the NHS and the pharmaceutical industry to address, but an opportunity to collaborate could bring them closer together for the benefit of all. PA Consulting Group colleagues Dr Stephen Black and Ian Rhodes explain.
Innovative approaches to health priorities through NHS and industry collaboration
Partnering with the pharmaceutical industry and bringing together a diverse group of experts is a novel but valuable approach for the NHS to address healthcare challenges, write Robyn Hudson and colleagues.
